Space Travel News  
Stem Cell Sales To Top 35 Million Dollars

Companies engaged in adult stem cell products will "start flooding into the market in the next four or five years," Robin Young, the author of the report and president and founder of Robin Young Consulting Grou, said. He tracks 106 companies involved in this field but says only about one-third will probably make it all the way to market with a viable product.
by Steve Mitchell
UPI Senior Medical Correspondent
Washington (UPI) Jan 08, 2007
Sales of adult stem cell products will more than double in 2007, exceeding $35 million and in the process opening the door for embryonic stem cell therapies, according to a medical industry analyst. The reason for the projected uptake is increased usage of the current products on the market, Robin Young, the author of the report and president and founder of Robin Young Consulting Group, told United Press International.

This consists predominantly of products made by Blackstone Medical, Nutech and Osiris. These three companies will account for the $35 million plus in sales projected for 2007, Young said. Adult stem cell products generated sales of $16.4 million in 2006.

Young has a breakdown for how much each company is expected to generate in sales in 2007 but won't release that data until February at the Stem Cell Summit in San Diego that his company sponsors.

About 70 percent of the products are used in spine fusion cases, but other uses include situations where there is concern about a patient's ability to grow bone and non-union fractures or fractures that are not healing well.

The products are relatively new, but now that physicians are gaining more experience with them, they seem to be working well and are very promising, Young said.

The field is expected to grow rapidly over the next couple of years, exploding from $35 million this year to $178 million by 2009.

"Big growth," Young said.

The success "will excite capital markets and we should expect to see a fair amount of capital coming in to help support these companies," he added.

By 2009 there could be as many as seven or eight companies in this area, including TiGenix, Aastrom, Cytori and Harvest Technologies.

Cartilage repair will become a big niche in this field, but bone growth and repair will still account for the majority of products, Young said.

Companies engaged in adult stem cell products will "start flooding into the market in the next four or five years," he said. He tracks 106 companies involved in this field but says only about one-third will probably make it all the way to market with a viable product.

The adult stem cell products also will make it easier for embryonic stem cell-based therapies to reach the market.

"These products are creating markets, demonstrating very clearly how to use stem cells on very standard kinds of procedures to accelerate healing and improve patient outcomes," Young said, calling it the beginning of the next phase of medicine.

"These products are growing so well, they set the stage for everything that comes next, including embryonic stem cells," he added.

Robert Lanza, vice president of research and scientific development at Advanced Cell Technology, a company pursuing therapies based on embryonic stem cells, told UPI he agreed the growth of adult stem cell therapies opens the door for other stem cell products.

His company plans to file an investigational new drug application with the Food and Drug Administration later this year for an embryonic stem cell therapy for treating vision disorders, followed by another IND in 2008 for cardiovascular disease.

Geron recently said it anticipates filing an IND this year for a treatment for spinal-cord injury derived from embryonic stem cells.

The Democrat-controlled Congress is expected to push for relaxing restrictions on federal funding of embryonic stem cell research -- although the move is shaky, given a virtually certain presidential veto -- and new research rekindled an already controversial subject.

Anthony Atala, head of Wake Forest's regenerative medicine institute, and colleagues recently announced they had found embryonic-like stem cells in amniotic fluid -- the liquid surrounding fetuses in the womb -- using a procedure that does not require destroying embryos.

However, these cells may not hold the same potential as embryonic stem cells. Lanza, who called the findings "an exciting breakthrough" that may speed the day embryonic stem cell-based therapies reach the clinic, noted the amniotic cells may not be able to do as many tricks as embryonic stem cells.

"Certainly, this isn't a replacement for embryonic stem cells," he said. "It would be premature to rule out any line of stem cell research," he added, noting that adult and embryonic stem cells have their respective strengths and weakness, and one may be more suitable for certain diseases or conditions than the other.

Source: United Press International

Related Links
Stem Cell News And Information
The Clone Age - Cloning, Stem Cells, Space Medicine



Memory Foam Mattress Review
Newsletters :: SpaceDaily :: SpaceWar :: TerraDaily :: Energy Daily
XML Feeds :: Space News :: Earth News :: War News :: Solar Energy News


An End To The Stem Cell Debate
Washington DC (UPI) Jan 08, 2007
In a provocative twist in the politically charged saga of stem cell research, scientists at Wake Forest University School of Medicine announced over the weekend they have found stem cells in amniotic fluid and placental tissue that have all the characteristics of embryonic stem cells and can be harvested without harming the developing fetus.







  • NASA Completes Review Milestone For Ares I Vehicle
  • ISRO Ready For Launch Of Multi-Mission PSLV
  • Boeing Secures Role In US-Australian Hypersonics Research Program
  • First South Korean Space Rocket To Launch In 2008

  • Arianespace To Launch ProtoStar I
  • India To Launch Latest Space Rocket



  • To The Space Station And Beyond In High Definition
  • Draper-Developed Trajectory Maneuvers ISS Without Using Propellant
  • Three Makes For A Crowd This New Year In Space

  • Microsoft Vista Launch Promoted With Space Ride Prize
  • NASA Extends Ares I Development Contract
  • Instant Noodle Inventor Dies At 96

  • China Upgrades Satellite Launch Tower
  • China Reports Breakthrough In Space Determination And Control Technology

  • NASA Awaits New FIRST Robotics Season
  • Futuristic Tools And Toys At Largest Consumer Electronics Show
  • Robotic Crawler Detects Wear In Power Lines

  • New Analysis of Viking Mission Results Indicates Presence of Life on Mars
  • CU-Boulder Proposal Selected As Finalist For Mission To Probe Past Climate Of Mars
  • It Is No Mirage
  • NASA Selects Proposals For Future Mars Missions And Studies

  • The content herein, unless otherwise known to be public domain, are Copyright Space.TV Corporation. AFP and UPI Wire Stories are copyright Agence France-Presse and United Press International. ESA Portal Reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space.TV Corp on any Web page published or hosted by Space.TV Corp. Privacy Statement